Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Price to FCF Ratio 2012–2026
Price to free cash flow (P/FCF) ratio for Supernus Pharmaceuticals Inc. (SUPN): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 64.79.
From: 06/30/2012To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Supernus Pharmaceuticals Inc. Price to FCF Ratio — FAQ
Supernus Pharmaceuticals Inc. (SUPN) price to fcf ratio over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's price to fcf ratio history?
The chart and table above show Supernus Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.